Identification of genes associated resistance of everolimus in cutaneous squamous cell carcinoma

GSE112079

Homo sapiens

5 Downloadable Samples

Affymetrix Human Gene 2.0 ST Array (hugene20st)

Submitter Supplied Information

Description

Metastatic squamous cell carcinoma suggest mTOR inhibitor as therapeutic agent because of activation of the PI3K/AKT/mTOR pathway. However, many therapeutic agents about cancer show resistance. Here, we investigated resistance network about mTOR inhibitor in skin squamous cell carcinoma using microarray. Our study identified that CCND1 overexpression increase resistance about mTOR inhibitor. The molecular mechanism may improve in therapeutic effects of mTOR inhibitor in cutaneous SCC.

PubMed ID

30568499

Publication Title

Identification of mTOR inhibitor-resistant genes in cutaneous squamous cell carcinoma.

Total Samples

Submitter’s Institution

Konyang university

Authors

Yu SL, Lee DC, Baek SW, Cho DY, Choi JG, Kang J

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-112079

No rows found